Literature DB >> 19560924

Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.

Luke R Odell1, Mikael T Nilsson, Johan Gising, Olof Lagerlund, Daniel Muthas, Anneli Nordqvist, Anders Karlén, Mats Larhed.   

Abstract

3-Amino-imidazo[1,2-a]pyridines have been identified as a novel class of Mycobacterium tuberculosis glutamine synthetase inhibitors. Moreover, these compounds represent the first drug-like inhibitors of this enzyme. A series of compounds exploring structural diversity in the pyridine and phenyl rings have been synthesized and biologically evaluated. Compound 4n was found to be the most potent inhibitor (IC(50)=0.38+/-0.02 microM). This compound was significantly more potent than the known inhibitors, l-methionine-SR-sulfoximine and phosphinothricin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560924     DOI: 10.1016/j.bmcl.2009.06.045

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

Review 2.  Recent advances on the transition-metal-catalyzed synthesis of imidazopyridines: an updated coverage.

Authors:  Gagandeep Kour Reen; Ashok Kumar; Pratibha Sharma
Journal:  Beilstein J Org Chem       Date:  2019-07-19       Impact factor: 2.883

3.  Efficient isocyanide-less isocyanide-based multicomponent reactions.

Authors:  Constantinos G Neochoritis; Silvia Stotani; Bhupendra Mishra; Alexander Dömling
Journal:  Org Lett       Date:  2015-03-31       Impact factor: 6.005

4.  Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.

Authors:  Garrett C Moraski; Lowell D Markley; Mayland Chang; Sanghyun Cho; Scott G Franzblau; Chang Hwa Hwang; Helena Boshoff; Marvin J Miller
Journal:  Bioorg Med Chem       Date:  2012-02-16       Impact factor: 3.641

5.  Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.

Authors:  Garrett C Moraski; Lowell D Markley; Philip A Hipskind; Helena Boshoff; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal:  ACS Med Chem Lett       Date:  2011-06-09       Impact factor: 4.345

6.  Metal-free, efficient hydrazination of imidazo[1,2-a]pyridine with diethyl azodicarboxylate in neutral media.

Authors:  Yuanxiang Wang; Brendan Frett; Nick McConnell; Hong-Yu Li
Journal:  Org Biomol Chem       Date:  2015-03-14       Impact factor: 3.876

Review 7.  Groebke-Blackburn-Bienaymé multicomponent reaction: emerging chemistry for drug discovery.

Authors:  Saad Shaaban; Bakr F Abdel-Wahab
Journal:  Mol Divers       Date:  2015-05-28       Impact factor: 2.943

8.  Glutamate dehydrogenase and glutamine synthetase are regulated in response to nitrogen availability in Myocbacterium smegmatis.

Authors:  Catriona J Harper; Don Hayward; Martin Kidd; Ian Wiid; Paul van Helden
Journal:  BMC Microbiol       Date:  2010-05-11       Impact factor: 3.605

9.  Indium triflate promoted one-pot multicomponent synthesis of structurally diverse 3-amino-imidazo[1,2-a]pyridines.

Authors:  Suman Swami; Arunava Agarwala; Rahul Shrivastava
Journal:  Mol Divers       Date:  2016-09-26       Impact factor: 2.943

10.  Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitors.

Authors:  Johan Gising; Mikael T Nilsson; Luke R Odell; Samir Yahiaoui; Martin Lindh; Harini Iyer; Achyut M Sinha; Bachally R Srinivasa; Mats Larhed; Sherry L Mowbray; Anders Karlén
Journal:  J Med Chem       Date:  2012-03-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.